Board Thread:Game Discussion/@comment-116.68.122.163-20180628145149/@comment-29898480-20180629211018

Amrosa, not sure why you're focused antimicrobials. Although they have unique usage patterns which have suppressed investment (it's been a well known issue since I entered the business and it's a front burner topic, see: FDA announcement from 2 weeks ago). Nonetheless Achoagen, Melinta, and many others are still working away. I had my ear bent at the JPM conf this past January by an old VC who had this great new antimicrobial start-up he's doing.